Treatment of Osteoporosis in Chronic Kidney Disease Population.

Osteoporosis is treated similarly in all patients with GFR greater than 30 mL/min. In patients with fragility fracture with a GFR less than 30 mL/min, correct diagnosis through biopsy and bone turnover markers of adynamic bone disease, hyperparathyroidism, osteomalacia, or osteoporosis is important because antiresorptive medications will not benefit a patient with adynamic bone disease.